Tys-Jacobs, S., et al. “Vitamin D and Calcium Dysregulation in the Polycystic Ovarian Syndrome”. Steroids 64, no. 6 (1999): 430–35.

Vandenbroucke, J. P., et al. “Increased Risk of Venous Thrombosis in Oral-Contraceptive Users Who Are Carriers of Factor V Leiden Mutation”. Lancet 344, no. 8935 (1994): 1453–57.

Van Hylckama, V. A., et al. “The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-Control Study”. British Medical Journal 339 (2009): b2921. Vasilakis, C., et al. “Risk of Idiopathic Venous Thromboembolism in Users of Progestagens Alone”. Lancet 354, no. 9190 (1999): 1610–11.

Vasilakis, C., et al. “The Risk of Venous Thromboembolism in Users of Postcoital Contraceptive Pills”. Contraception 52, no. 2 (1999): 79–83.

Vessey, M., et al. “Oral Contraceptive Use and Cancer. Findings in a Large Cohort Study 1968–2004”. British Journal of Cancer 95, no. 3 (2006): 385–89.

Vinogradova, Y., et al. “Use of Combined Oral Contraceptives and Risk of Venous Tromboembolism: Nested Case-Control Studies Using the QResearch and CPRD Databases”. British Medical Journal 350 (2015): h2135.

Wang, Q., et al. “Effects of Hormonal Contraception on Systemic Metabolism: Cross- Sectional and Longitudinal Evidence”. International Journal of Epidemiology 45, no. 5 (2016): 1445–57.

Westhof, C. L., et al. “Clotting Factor Changes During the First Cycle of Oral Contraceptive Use”. Contraception 93, no. 1 (2016): 70–76.

Williams, M. J., et al. “Association Between C-Reactive Protein, Metabolic Cardiovascular Risk Factors, Obesity, and Oral Contraceptive Use in Young Adults”. International Journal of Obesity and Related Metabolic Disorders 28, no. 8 (2004): 998–1003.

Yan, Y., et al. “Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder Trough Inhibition of NLRP3 Infammasome Activation”. Immunity 38, no. 6 (2013): 1154–63.

9. Возьмите под контроль свои перепады настроения, тревожное расстройство и депрессию

Akhondzadeh, S., et al. “Passionfower in the Treatment of Generalized Anxiety: A Pilot Double-Blind Randomized Controlled Trial with Oxazepam”. Journal of Clinical Pharmacy and Therapeutics 26, no. 5 (2001): 363–67.

Almey, A., et al. “Estrogen Receptors in the Central Nervous System and Their Implication for Dopamine-Dependent Cognition in Females”. Hormones and Behavior 74 (2015): 125–38.